Evidence map›Paper›PMID 39686743›Full record

ArticleJournal of neurotrauma2025

Evolution of Lipid Metabolism in the Injured Mouse Spinal Cord.

Natalie E Scholpa, Epiphani C Simmons, Justin M Snider, Kelsey Barrett, Lauren G Buss, Rick G Schnellmann

Abstract read
In one paragraph

Article in Journal of neurotrauma, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Natalie E ScholpaDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona, USA.ORCID 0000-0002-1234-5482
Epiphani C SimmonsDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona, USA.
Justin M SniderDepartment of Nutritional Sciences, College of Agriculture and Life Sciences, University of Arizona, Tucson, Arizona, USA.
Kelsey BarrettDepartment of Nutritional Sciences, College of Agriculture and Life Sciences, University of Arizona, Tucson, Arizona, USA.
Lauren G BussDepartment of Nutritional Sciences, College of Agriculture and Life Sciences, University of Arizona, Tucson, Arizona, USA.
Rick G SchnellmannDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona, USA.

Funding

VITAMIN AP30CA023074 · NCI · UNIVERSITY OF ARIZONA · PI Dan Theodorescu · 1985 to 2026
$110.2M
Translational research in Alzheimer’s Disease and Related Dementias (TRADD)T32AG061897 · NIA · UNIVERSITY OF ARIZONA · PI BRINTON, ROBERTA EILEEN · 2018 to 2022
$1.3M
5-HT1F receptor mediated mitochondrial biogenesis for the treatment of spinal cord injuryF31NS115413 · NINDS · UNIVERSITY OF ARIZONA · PI SIMMONS, EPIPHANI · 2020 to 2020
$37k
BLRD VA IK2 BX005218NCI NIH HHS P30 CA023074NIA NIH HHS T32 AG061897NINDS NIH HHS F31 NS115413
6 · The paper itself

Abstract

Following spinal cord injury (SCI), there is a short-lived recovery phase that ultimately plateaus. Understanding changes within the spinal cord over time may facilitate targeted approaches to prevent and/or reverse this plateau and allow for continued recovery. Untargeted metabolomics revealed distinct metabolic profiles within the injured cord during recovery (7 days postinjury [DPI]) and plateau (21 DPI) periods in a mouse model of severe contusion SCI. Alterations in lipid metabolites, particularly those involved in phospholipid (PL) metabolism, largely contributed to overall differences. PLs are hydrolyzed by phospholipases A2 (PLA2s), yielding lysophospholipids (LPLs) and fatty acids (FAs). PL metabolites decreased between 7 and 21 DPI, whereas LPLs increased at 21 DPI, suggesting amplified PL metabolism during the plateau phase. Expression of various PLA2s also differed between the two time points, further supporting dysregulation of PL metabolism during the two phases of injury. FAs, which can promote inflammation, mitochondrial dysfunction, and neuronal damage, were increased regardless of time point. Carnitine can bind with FAs to form acylcarnitines, lessening FA-induced toxicity. In contrast to FAs, carnitine and acylcarnitines were increased at 7 DPI, but decreased at 21 DPI, suggesting a loss of carnitine-mediated mitigation of FA toxicity at the later time point, which may contribute to the cessation of recovery post-SCI. Alterations in oxidative phosphorylation and tricarboxylic acid cycle metabolites were also observed, indicating persistent although dissimilar disruptions in mitochondrial function. These data aid in increasing our understanding of lipid metabolism following SCI and have the potential to lead to new biomarkers and/or therapeutic strategies.

Indexed as

Lipid MetabolismSpinal CordSpinal Cord InjuriesAnimalsCitric Acid CycleDisease Models, AnimalFemaleLysophospholipidsMetabolomicsMiceMice, Inbred C57BLOxidative PhosphorylationPhospholipases A2PhospholipidsRecovery of FunctionTime FactorsLysophospholipidsPhospholipases A2Phospholipidscarnitinelipidsmetabolomicsphospholipidsspinal cord injury

Identifiers

PMID39686743
PMCPMC12056580

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.